155 related articles for article (PubMed ID: 29428730)
21. Sphingosine kinase 2 inhibitor ABC294640 suppresses neuronal excitability and inhibits multiple endogenously and exogenously expressed voltage-gated ion channels in cultured cells.
Zhang F; Hu W; Qu L; Cang C
Channels (Austin); 2020 Dec; 14(1):216-230. PubMed ID: 32615066
[TBL] [Abstract][Full Text] [Related]
22. A Phase I Study of ABC294640, a First-in-Class Sphingosine Kinase-2 Inhibitor, in Patients with Advanced Solid Tumors.
Britten CD; Garrett-Mayer E; Chin SH; Shirai K; Ogretmen B; Bentz TA; Brisendine A; Anderton K; Cusack SL; Maines LW; Zhuang Y; Smith CD; Thomas MB
Clin Cancer Res; 2017 Aug; 23(16):4642-4650. PubMed ID: 28420720
[No Abstract] [Full Text] [Related]
23. Sphingosine kinase inhibition exerts both pro- and anti-atherogenic effects in low-density lipoprotein receptor-deficient (LDL-R(-/-)) mice.
Poti F; Bot M; Costa S; Bergonzini V; Maines L; Varga G; Freise H; Robenek H; Simoni M; Nofer JR
Thromb Haemost; 2012 Mar; 107(3):552-61. PubMed ID: 22234485
[TBL] [Abstract][Full Text] [Related]
24. Proteasomal degradation of sphingosine kinase 1 and inhibition of dihydroceramide desaturase by the sphingosine kinase inhibitors, SKi or ABC294640, induces growth arrest in androgen-independent LNCaP-AI prostate cancer cells.
McNaughton M; Pitman M; Pitson SM; Pyne NJ; Pyne S
Oncotarget; 2016 Mar; 7(13):16663-75. PubMed ID: 26934645
[TBL] [Abstract][Full Text] [Related]
25. SphK1-targeted miR-6784 inhibits functions of skin squamous cell carcinoma cells.
Gong ZH; Ji J; Yao J; Ji JF; Jiang Y; Gao G; Feng Z
Aging (Albany NY); 2021 Jan; 13(3):3726-3741. PubMed ID: 33465049
[TBL] [Abstract][Full Text] [Related]
26. Sphingosine kinase-2 is overexpressed in large granular lymphocyte leukaemia and promotes survival through Mcl-1.
LeBlanc FR; Pearson JM; Tan SF; Cheon H; Xing JC; Dunton W; Feith DJ; Loughran TP
Br J Haematol; 2020 Aug; 190(3):405-417. PubMed ID: 32124438
[TBL] [Abstract][Full Text] [Related]
27. Downregulation of Critical Oncogenes by the Selective SK2 Inhibitor ABC294640 Hinders Prostate Cancer Progression.
Schrecengost RS; Keller SN; Schiewer MJ; Knudsen KE; Smith CD
Mol Cancer Res; 2015 Dec; 13(12):1591-601. PubMed ID: 26271487
[TBL] [Abstract][Full Text] [Related]
28. GDC-0084 inhibits cutaneous squamous cell carcinoma cell growth.
Ding LT; Zhao P; Yang ML; Lv GZ; Zhao TL
Biochem Biophys Res Commun; 2018 Sep; 503(3):1941-1948. PubMed ID: 30072096
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of sphingosine kinase-2 ablates androgen resistant prostate cancer proliferation and survival.
Gestaut MM; Antoon JW; Burow ME; Beckman BS
Pharmacol Rep; 2014 Feb; 66(1):174-8. PubMed ID: 24905325
[TBL] [Abstract][Full Text] [Related]
30. Suppression of colitis-driven colon cancer in mice by a novel small molecule inhibitor of sphingosine kinase.
Chumanevich AA; Poudyal D; Cui X; Davis T; Wood PA; Smith CD; Hofseth LJ
Carcinogenesis; 2010 Oct; 31(10):1787-93. PubMed ID: 20688834
[TBL] [Abstract][Full Text] [Related]
31. I-BET726 suppresses human skin squamous cell carcinoma cell growth in vitro and in vivo.
Liu Z; Li P; Yang YQ; Cai S; Lin X; Chen MB; Guo H
Cell Death Dis; 2020 May; 11(5):318. PubMed ID: 32371868
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of sphingosine kinase-2 suppresses inflammation and attenuates graft injury after liver transplantation in rats.
Liu Q; Rehman H; Shi Y; Krishnasamy Y; Lemasters JJ; Smith CD; Zhong Z
PLoS One; 2012; 7(7):e41834. PubMed ID: 22848628
[TBL] [Abstract][Full Text] [Related]
33. Antiestrogenic effects of the novel sphingosine kinase-2 inhibitor ABC294640.
Antoon JW; White MD; Meacham WD; Slaughter EM; Muir SE; Elliott S; Rhodes LV; Ashe HB; Wiese TE; Smith CD; Burow ME; Beckman BS
Endocrinology; 2010 Nov; 151(11):5124-35. PubMed ID: 20861237
[TBL] [Abstract][Full Text] [Related]
34. Experimental osteoarthritis in rats is attenuated by ABC294640, a selective inhibitor of sphingosine kinase-2.
Fitzpatrick LR; Green C; Maines LW; Smith CD
Pharmacology; 2011; 87(3-4):135-43. PubMed ID: 21346391
[TBL] [Abstract][Full Text] [Related]
35. Suppression of c-Myc and RRM2 expression in pancreatic cancer cells by the sphingosine kinase-2 inhibitor ABC294640.
Lewis CS; Voelkel-Johnson C; Smith CD
Oncotarget; 2016 Sep; 7(37):60181-60192. PubMed ID: 27517489
[TBL] [Abstract][Full Text] [Related]
36. Targeting sphingosine kinase 1/2 by a novel dual inhibitor SKI-349 suppresses non-small cell lung cancer cell growth.
Xue Y; Jiang K; Ou L; Shen M; Yang Y; Lu J; Xu W
Cell Death Dis; 2022 Jul; 13(7):602. PubMed ID: 35831279
[TBL] [Abstract][Full Text] [Related]
37. Ceramides promote apoptosis for virus-infected lymphoma cells through induction of ceramide synthases and viral lytic gene expression.
Dai L; Trillo-Tinoco J; Bai A; Chen Y; Bielawski J; Del Valle L; Smith CD; Ochoa AC; Qin Z; Parsons C
Oncotarget; 2015 Sep; 6(27):24246-60. PubMed ID: 26327294
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of sphingosine kinase-2 in a murine model of lupus nephritis.
Snider AJ; Ruiz P; Obeid LM; Oates JC
PLoS One; 2013; 8(1):e53521. PubMed ID: 23301082
[TBL] [Abstract][Full Text] [Related]
39. Impact of sphingosine kinase 2 deficiency on the development of TNF-alpha-induced inflammatory arthritis.
Baker DA; Eudaly J; Smith CD; Obeid LM; Gilkeson GS
Rheumatol Int; 2013 Oct; 33(10):2677-81. PubMed ID: 23011090
[TBL] [Abstract][Full Text] [Related]
40. Combined anticancer effects of sphingosine kinase inhibitors and sorafenib.
Beljanski V; Knaak C; Zhuang Y; Smith CD
Invest New Drugs; 2011 Dec; 29(6):1132-42. PubMed ID: 20473784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
